Clinical trials recruiting for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| YTS109 cell | 5 |
| CD19 targeted CAR-T cells | 1 |
| CD19- BCMA CAR-T cells | 1 |
| anti-CD19/BCMA U CAR T cells | 1 |
Self-screener
Recruiting trials
- A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
Related conditions
Trials recruiting for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.